cardiogenic shock and iabp

54
Athanassios Antonopoulos MD, PhD, FESC, FACC U.O. Cardiologia Faenza (RA), Emilia Romagna, IT

Upload: athanassios-antonopoulos

Post on 24-Jan-2017

305 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Cardiogenic Shock and IABP

Athanassios Antonopoulos MD, PhD, FESC, FACCU.O. Cardiologia Faenza (RA), Emilia Romagna, IT

Page 2: Cardiogenic Shock and IABP

No conflict of interest

Page 3: Cardiogenic Shock and IABP
Page 4: Cardiogenic Shock and IABP
Page 5: Cardiogenic Shock and IABP

Goldberg RJ et al, Circulation 2009

Page 6: Cardiogenic Shock and IABP

Goldberg RJ et al, Circulation 2009

mortality

Page 7: Cardiogenic Shock and IABP
Page 8: Cardiogenic Shock and IABP

SHOCK Trial: Age < 75

0

20

40

60

80

30 Day Mortality

41.4%

56.8%%

P < .01

0

20

40

60

80

6 Month Mortality

44.9%

65.0%

Hochman et al, NEJM 1999; 341:625.

Immediate Revascularization StrategyMedical Stabilization as an Initial Strategy

P < 0.002

Page 9: Cardiogenic Shock and IABP

SHOCK Trial: Age > 75

0

20

40

60

80

30 Day Mortality

75.0%

53.1%%

P < .01

0

20

40

60

80

6 Month Mortality

79.2%

56.3%

Hochman et al, NEJM 1999; 341:625.

Immediate Revascularization StrategyMedical Stabilization as an Initial Strategy

P < 0.003

Page 10: Cardiogenic Shock and IABP

Long-term follow-up of the SHOCK trial cohort. Early revascularization (ERV) is associated with sustained benefit.

Harmony R. Reynolds, and Judith S. Hochman Circulation. 2008;117:686-697

Copyright © American Heart Association, Inc. All rights reserved.

Page 11: Cardiogenic Shock and IABP

Functional status in the SHOCK trial. The majority of patients who survived 2 weeks after discharge had good functional status (and quality of life) at that time point.

Harmony R. Reynolds, and Judith S. Hochman Circulation. 2008;117:686-697

Copyright © American Heart Association, Inc. All rights reserved.

Page 12: Cardiogenic Shock and IABP

Causes

Page 13: Cardiogenic Shock and IABP

Cardiogenic shock is a spectrum

Page 14: Cardiogenic Shock and IABP

Range of LVEF in studies of heart failure and in the SHOCK trial.

Harmony R. Reynolds, and Judith S. Hochman Circulation. 2008;117:686-697

Page 15: Cardiogenic Shock and IABP
Page 16: Cardiogenic Shock and IABP
Page 17: Cardiogenic Shock and IABP
Page 18: Cardiogenic Shock and IABP
Page 19: Cardiogenic Shock and IABP

Figure 3. Iatrogenic shock.

Harmony R. Reynolds, and Judith S. Hochman Circulation. 2008;117:686-697

Page 20: Cardiogenic Shock and IABP
Page 21: Cardiogenic Shock and IABP

SHOCK Trial

Page 22: Cardiogenic Shock and IABP
Page 23: Cardiogenic Shock and IABP
Page 24: Cardiogenic Shock and IABP
Page 25: Cardiogenic Shock and IABP
Page 26: Cardiogenic Shock and IABP
Page 27: Cardiogenic Shock and IABP
Page 28: Cardiogenic Shock and IABP

Tsuneyoshi I Crit Care Med 2001; 29:487

Page 29: Cardiogenic Shock and IABP
Page 30: Cardiogenic Shock and IABP
Page 32: Cardiogenic Shock and IABP

Levosimedan very early in cardiogenic shock, effects lasting for at least 72 h,no pro-arrhythmic effects

Page 33: Cardiogenic Shock and IABP
Page 34: Cardiogenic Shock and IABP
Page 35: Cardiogenic Shock and IABP
Page 36: Cardiogenic Shock and IABP

IMPORTANT

Page 37: Cardiogenic Shock and IABP

Algorithm for revascularization strategy in cardiogenic shock, from ACC/AHA guidelines. Whether shock onset occurs early or late after MI, rapid IABP placement and

angiography are recommended.

Harmony R. Reynolds, and Judith S. Hochman Circulation. 2008;117:686-697

Page 38: Cardiogenic Shock and IABP
Page 39: Cardiogenic Shock and IABP
Page 40: Cardiogenic Shock and IABP

Sheidt, NEJM 1973; Mueller, Circ 1972

Page 41: Cardiogenic Shock and IABP

One complete cardiac cycle and the corresponding waveform of the IABP during inflation and deflation.

Murli Krishna, and Kai Zacharowski Contin Educ Anaesth Crit Care Pain 2009;9:24-28

© The Board of Management and Trustees of the British Journal of [2009]. All rights reserved. For Permissions, please email: [email protected]

Page 42: Cardiogenic Shock and IABP

Remember the IABP curve …

Page 43: Cardiogenic Shock and IABP

Endocardial Viability Ratio: DPTI / TTI

DPTI= the net area between aortic pressure and left ventricular pressure during diastole. TTI= the area under the LV systolic curve is well correlated w myocardial oxygen demand for total left ventricular work

DPTI = oxygen supply

TTI = oxygen demand

Page 44: Cardiogenic Shock and IABP
Page 45: Cardiogenic Shock and IABP

Prondzinsky et al. SHOCK 2012;37:378-384

Page 46: Cardiogenic Shock and IABP

Gaps !

Page 47: Cardiogenic Shock and IABP
Page 48: Cardiogenic Shock and IABP

patients for surgery

Page 49: Cardiogenic Shock and IABP
Page 50: Cardiogenic Shock and IABP

Perera, et al ACC 2012

Page 51: Cardiogenic Shock and IABP

IABP in high risk pts for non-cardiac surgery

patients with coronary artery disease (CAD) for whom bypass grafting is not an option due to: (1) inoperable CAD; (2) a severe coexisting disease process (such as a malignancy); or (3) the emergent nature of the noncardiac procedure.

The decision analysis suggests that patients whose preoperative assessment places them at very high risk for postoperative complications (Goldman class IV or Detsky class III undergoing major surgery) may benefit the most from prophylactic placement of an IABP prior to noncardiac surgery.

Page 52: Cardiogenic Shock and IABP
Page 53: Cardiogenic Shock and IABP

Thank you….

Page 54: Cardiogenic Shock and IABP